| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 09/04/2001 | US6284747 Pharmaceutical formulation |
| 09/04/2001 | US6284272 Pharmaceutical compositions containing an effervescent acid-base couple |
| 08/30/2001 | WO2001062801A2 Humanized antibodies that sequester amyloid beta peptide |
| 08/30/2001 | US20010018521 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/29/2001 | EP1127893A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 08/29/2001 | EP1126861A2 Compositions comprising oleum melaleuca |
| 08/29/2001 | EP1126840A1 5ht(1) receptor agonists and metoclopramide for the treatment of migraine |
| 08/29/2001 | EP1126823A2 A process for the preparation of suspensions of drug particles for inhalation delivery |
| 08/29/2001 | EP0957894A4 Hair coloring compositions |
| 08/29/2001 | EP0952811A4 Hair coloring compositions |
| 08/29/2001 | EP0951270A4 Hair coloring compositions |
| 08/29/2001 | EP0946133A4 Hair coloring compositions |
| 08/29/2001 | EP0912156B1 Cooling effect of antiperspirant composition |
| 08/29/2001 | CN1310629A Coadministration of ACAT and MMP inhibitors for the treatment of atherosclerotic lesions |
| 08/29/2001 | CN1310620A Use of glucose uptake enhancer for reducing apoptosis |
| 08/29/2001 | CN1070048C Hair coloring composition |
| 08/29/2001 | CN1070047C Hair dying composition |
| 08/29/2001 | CN1070046C Shampoo-conditioner composition |
| 08/28/2001 | US6280975 Adjusted interleukin polypeptide for use in the treatment of myelomas, tumors, osteoporosis and autoimmune diseases |
| 08/28/2001 | US6280777 Soya extract, process for its preparation and pharmaceutical composition |
| 08/28/2001 | US6280737 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |
| 08/23/2001 | WO2001005356A3 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
| 08/23/2001 | US20010016659 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/22/2001 | EP1125585A1 Remedies for immunological diseases |
| 08/22/2001 | EP1124828A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/22/2001 | CN1309640A Quinoline derivs. |
| 08/21/2001 | US6277881 Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids |
| 08/21/2001 | CA2294595C Inhibiting bone resorption |
| 08/16/2001 | WO2000057866A3 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 08/16/2001 | US20010014801 Robotic arm DLUs for performing surgical tasks |
| 08/16/2001 | US20010014741 Antiallergens, antihistamines, bronchodilator |
| 08/16/2001 | US20010014689 Nervous system disorders |
| 08/16/2001 | EP1123717A2 Estrogen agonist/antagonist and statin containing compositions for treating osteoporosis and lowering cholesterol |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123276A1 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 08/16/2001 | EP1123088A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 08/16/2001 | EP0552256B1 Method of treating or preventing type 1 diabetes by oral administration of insulin |
| 08/15/2001 | CN1308631A Heterocyclic derivatives which inhibit factor xa |
| 08/15/2001 | CN1308546A Immunomodulators for vaccines |
| 08/15/2001 | CN1308541A Extracts of zanthoxylum bungeanum, pharmaceuti-cal and cosmetic formulations containing them |
| 08/15/2001 | CN1308530A Use of tricyclic antidepressants for local analgesia |
| 08/15/2001 | CN1307867A Mizoribine tablet with improved color |
| 08/14/2001 | CA2150871C Cosmetic sunscreens made of a synergetic mix of filters and their uses |
| 08/09/2001 | WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057032A1 C10 ester substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 08/09/2001 | WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | WO2001056583A1 Medicine containing anemonin as effective component for treating aseptic inflammation |
| 08/09/2001 | WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
| 08/09/2001 | WO2001056570A1 Remedies or preventives for pulmonary insufficiency containing diaminotrifluoromethylpyridine derivatives |
| 08/09/2001 | WO2001014376A8 Novel spiro compounds |
| 08/09/2001 | WO2000045795A3 Topical sprays comprising a film forming composition |
| 08/09/2001 | US20010012896 Crystallization, heating |
| 08/09/2001 | US20010012856 Compositions and methods for the treatment of anorectal disorders |
| 08/09/2001 | US20010012840 Topical transdermal treatments |
| 08/09/2001 | CA2399123A1 Medicament for treating aseptic inflammations containing anemonin as effective component |
| 08/09/2001 | CA2396197A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs) |
| 08/09/2001 | CA2368541A1 C10 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | CA2368540A1 C7 carbonate substituted taxanes as antitumor agents |
| 08/09/2001 | CA2368534A1 C7 heterosubstituted acetate taxanes as antitumor agents |
| 08/09/2001 | CA2368510A1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 08/09/2001 | CA2368151A1 C10 carbonate substituted taxanes as antitumor agents |
| 08/08/2001 | EP1121345A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1- 2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 |
| 08/08/2001 | EP1121120A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 08/08/2001 | EP1121112A2 Storable active substance concentrate with formoterol |
| 08/08/2001 | CN1307561A Novel VLA-4 inhibitor: oMePUPA-V |
| 08/08/2001 | CN1307559A Substituted beta-diketones and their use |
| 08/08/2001 | CN1306818A Medicine for treating abacterial inflammation and its extraction method |
| 08/08/2001 | CN1306813A Weak ethoxylation dehydrated sorbitol ester composition of washing keratin material |
| 08/08/2001 | CN1069321C New inhibitors of platelet aggregation |
| 08/08/2001 | CN1069191C Compressed gas packagings using polyoxyethylene glyleryl oleates description |
| 08/07/2001 | US6271253 Cyclooxygenase inhibitors |
| 08/07/2001 | US6271213 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
| 08/07/2001 | US6270769 Providing the antigen to which the ctl response is desired and providing an antigen formulation which consists of two or more of a stabilizing detergent, a micelle-forming agent, and an oil; antigen lacking an immunostimulating peptide component |
| 08/07/2001 | US6270534 Comprising two-electron oxidoreductase, its corresponding donor, and one basic amino acid in reaction support such as water; ready-to-use, stability, color intensity, compatibility; homogeneity; curling |
| 08/02/2001 | WO2001055178A2 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | WO2001055130A2 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors |
| 08/02/2001 | WO2001055122A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 08/02/2001 | WO2001054700A1 Pharmaceutical preparation and method for treatment of diabetes |
| 08/02/2001 | US20010011136 Anticancer agents |
| 08/02/2001 | US20010011135 Anticancer agents |
| 08/02/2001 | CA2398206A1 Pharmaceutical preparation and method for treatment of diabetes |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/01/2001 | EP1120117A1 Method of increasing the production of eggs and strengthening eggshells in poultry |
| 08/01/2001 | EP1037627B1 Use of 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid and of pharmaceutically acceptable salts thereof for the manufacture of a medicament for the treatment of non-allergic ophthalmic inflammatory disorders and for the prevention of ocular neovascularization |
| 08/01/2001 | CN1306520A Non-yellowing para-tertiary-alkyl phenyl substituted triazine and pyrimidine ultraviolet light absorbers |
| 08/01/2001 | CN1306511A Novel heterocyclic compounds |
| 08/01/2001 | CN1306442A Improement in or relating to contrast agents |
| 08/01/2001 | CN1306441A Pare-hydrogen labelled agents and their use in magnetic resonance imaging |
| 08/01/2001 | CN1306432A Deoxy and oxygen-substituted sugar-contg. 14-aminosteriod compounds for use as antiarrhythmic |
| 08/01/2001 | CN1306416A Desensitizing dentifrice contg. potassium and tin salts |
| 07/31/2001 | US6268374 Uracil reductase inactivators |
| 07/31/2001 | US6268369 5-(heterocyclic alkyl)-6-aryl-dihydropyrimidines |
| 07/31/2001 | US6268346 Having high biological activity of the same type as the known natural compound bpc, but with shorter amino acid chains. |
| 07/31/2001 | US6268344 Associated with sepsis, purpura fulminans, meningococcal sepsis, bone marrow and other transplantations, severe burns, pregnancy, major surgery, severe trauma, or ards. |
| 07/31/2001 | US6268337 Methods for treating vascular disorders using activated protein C |
| 07/31/2001 | US6267995 Isolated composition obtained by extracting lepidium meyenii roots with aqueous solvent, substantially free of cellulose, comprising benzyl isothiocyanate, lepidium sterol component, lepidium fatty acid component, and macamide component |